What is the genetics of antiphospholipid antibodies/syndrome?

Thomas L. Ortel, Pier Luigi Meroni, Marta E. Alarcón-Riquelme, Maria O. Borghi, Joan T. Merrill

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

An inherited risk for the occurrence of antiphospholipid antibodies (aPLs), with or without the clinical manifestations associated with antiphospholipid syndrome (APS), is supported by multiple lines of evidence. Family members of patients with APS, whether primary or associated with another autoimmune disease, are more likely to have elevated aPL levels. Multiple reports have described multiplex families with two or more family members with APS (or APS and another autoimmune disorder), and there is a strong association between aPL and APS with specific genes and gene alleles in the major histocompatibility complex. Genetic risk factors also appear to contribute to the prothrombotic risk in individual patients with aPL. The data would suggest that the development of these antibodies, as well as the clinical syndrome, reflects a complex interplay of inherited and acquired risk factors. Ongoing studies designed to identify and characterize genes associated with the development of aPL will improve our understanding of this complex autoimmune disorder and may provide a better understanding of which patients with aPL will develop clinical manifestations of the syndrome.

Original languageEnglish
Title of host publicationAntiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies
PublisherSpringer US
Pages41-56
Number of pages16
ISBN (Print)9781461431947, 9781461431930
DOIs
Publication statusPublished - Jan 1 2012

Fingerprint

Antiphospholipid Syndrome
Genes
Antiphospholipid Antibodies
Major Histocompatibility Complex
Autoimmune Diseases
Alleles
Antibodies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ortel, T. L., Meroni, P. L., Alarcón-Riquelme, M. E., Borghi, M. O., & Merrill, J. T. (2012). What is the genetics of antiphospholipid antibodies/syndrome? In Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies (pp. 41-56). Springer US. https://doi.org/10.1007/978-1-4614-3194-7_3

What is the genetics of antiphospholipid antibodies/syndrome? / Ortel, Thomas L.; Meroni, Pier Luigi; Alarcón-Riquelme, Marta E.; Borghi, Maria O.; Merrill, Joan T.

Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies. Springer US, 2012. p. 41-56.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ortel, TL, Meroni, PL, Alarcón-Riquelme, ME, Borghi, MO & Merrill, JT 2012, What is the genetics of antiphospholipid antibodies/syndrome? in Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies. Springer US, pp. 41-56. https://doi.org/10.1007/978-1-4614-3194-7_3
Ortel TL, Meroni PL, Alarcón-Riquelme ME, Borghi MO, Merrill JT. What is the genetics of antiphospholipid antibodies/syndrome? In Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies. Springer US. 2012. p. 41-56 https://doi.org/10.1007/978-1-4614-3194-7_3
Ortel, Thomas L. ; Meroni, Pier Luigi ; Alarcón-Riquelme, Marta E. ; Borghi, Maria O. ; Merrill, Joan T. / What is the genetics of antiphospholipid antibodies/syndrome?. Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies. Springer US, 2012. pp. 41-56
@inbook{18e0b3b135414443be012f94e3bb2a7f,
title = "What is the genetics of antiphospholipid antibodies/syndrome?",
abstract = "An inherited risk for the occurrence of antiphospholipid antibodies (aPLs), with or without the clinical manifestations associated with antiphospholipid syndrome (APS), is supported by multiple lines of evidence. Family members of patients with APS, whether primary or associated with another autoimmune disease, are more likely to have elevated aPL levels. Multiple reports have described multiplex families with two or more family members with APS (or APS and another autoimmune disorder), and there is a strong association between aPL and APS with specific genes and gene alleles in the major histocompatibility complex. Genetic risk factors also appear to contribute to the prothrombotic risk in individual patients with aPL. The data would suggest that the development of these antibodies, as well as the clinical syndrome, reflects a complex interplay of inherited and acquired risk factors. Ongoing studies designed to identify and characterize genes associated with the development of aPL will improve our understanding of this complex autoimmune disorder and may provide a better understanding of which patients with aPL will develop clinical manifestations of the syndrome.",
author = "Ortel, {Thomas L.} and Meroni, {Pier Luigi} and Alarc{\'o}n-Riquelme, {Marta E.} and Borghi, {Maria O.} and Merrill, {Joan T.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-3194-7_3",
language = "English",
isbn = "9781461431947",
pages = "41--56",
booktitle = "Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies",
publisher = "Springer US",

}

TY - CHAP

T1 - What is the genetics of antiphospholipid antibodies/syndrome?

AU - Ortel, Thomas L.

AU - Meroni, Pier Luigi

AU - Alarcón-Riquelme, Marta E.

AU - Borghi, Maria O.

AU - Merrill, Joan T.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - An inherited risk for the occurrence of antiphospholipid antibodies (aPLs), with or without the clinical manifestations associated with antiphospholipid syndrome (APS), is supported by multiple lines of evidence. Family members of patients with APS, whether primary or associated with another autoimmune disease, are more likely to have elevated aPL levels. Multiple reports have described multiplex families with two or more family members with APS (or APS and another autoimmune disorder), and there is a strong association between aPL and APS with specific genes and gene alleles in the major histocompatibility complex. Genetic risk factors also appear to contribute to the prothrombotic risk in individual patients with aPL. The data would suggest that the development of these antibodies, as well as the clinical syndrome, reflects a complex interplay of inherited and acquired risk factors. Ongoing studies designed to identify and characterize genes associated with the development of aPL will improve our understanding of this complex autoimmune disorder and may provide a better understanding of which patients with aPL will develop clinical manifestations of the syndrome.

AB - An inherited risk for the occurrence of antiphospholipid antibodies (aPLs), with or without the clinical manifestations associated with antiphospholipid syndrome (APS), is supported by multiple lines of evidence. Family members of patients with APS, whether primary or associated with another autoimmune disease, are more likely to have elevated aPL levels. Multiple reports have described multiplex families with two or more family members with APS (or APS and another autoimmune disorder), and there is a strong association between aPL and APS with specific genes and gene alleles in the major histocompatibility complex. Genetic risk factors also appear to contribute to the prothrombotic risk in individual patients with aPL. The data would suggest that the development of these antibodies, as well as the clinical syndrome, reflects a complex interplay of inherited and acquired risk factors. Ongoing studies designed to identify and characterize genes associated with the development of aPL will improve our understanding of this complex autoimmune disorder and may provide a better understanding of which patients with aPL will develop clinical manifestations of the syndrome.

UR - http://www.scopus.com/inward/record.url?scp=84949423498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949423498&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-3194-7_3

DO - 10.1007/978-1-4614-3194-7_3

M3 - Chapter

AN - SCOPUS:84949423498

SN - 9781461431947

SN - 9781461431930

SP - 41

EP - 56

BT - Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies

PB - Springer US

ER -